leadf
logo-loader
viewArcadia Biosciences Inc

Full interview: Arcadia Biosciences CEO highlights GoodHemp and GoodWheat wins from letter to shareholders

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matthew Plavan tells Proactive that the company’s new USDA-compliant seed line called GoodHemp is shaping up into a strong revenue spinner with over $3 million in pre-season seed purchase commitments.

Plavan also discussed company goals and objectives for in 2020, Plavan saying he feels 'good about progress we've made getting out of the gate.'

Quick facts: Arcadia Biosciences Inc

Price: 2.77 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $29.64 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Arcadia Biosciences reports strong 2Q revenue despite coronavirus impact

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matthew Plavan tells Proactive the California-based group's 2Q revenue growth was fueled by GLA sales and GoodWheat royalties. Plavan says the company also cinched a trio of recent GoodWheat agreements: a collaboration with Corner Foods to bring its...

on 08/13/2020

2 min read